Biomed Pharmaceuticals
Meningococcal Vaccine (Group A, C, Y & W-135)
Quadri Meningo Vaccine is used to prevent meningococcal disease.
Injection
Quadri Meningo Vaccine is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
No common side effects listed.
It is not known whether it is safe to consume alcohol with Quadri Meningo Vaccine. Please consult your doctor.
Quadri Meningo Vaccine is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Quadri Meningo Vaccine is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Mycophenolate mofetil Azathioprine Mercaptopurine Carbamazepine
Quadri Meningo Vaccine is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
It is usually given by injection into the muscle of the upper arm. Your doctor will advise you if and when you should receive a booster dose. Immunocompromised individuals or persons suffering from functional or anatomic asplenia (including sickle cell disease) should get it. People travelling to US & Europe or Hajj are advised to get vaccinated with Quadri Meningo Vaccine.
The Quadri Meningo Vaccine is a vaccine used to actively immunize individuals against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. It is approved for use in people aged 2 months through 55 years.
The vaccine should not be administered to individuals with a known allergy to any of its ingredients or similar medications. Signs of an allergic reaction include an itchy skin rash, shortness of breath, and swelling of the face or tongue. If you have experienced an allergic reaction to any medication in the past, inform your doctor.
A single booster dose may be administered to individuals aged 15 through 55 years who are at continued risk of getting meningococcal disease, provided at least 4 years have passed since their prior dose. If you have any concerns, consult your doctor.
The vaccine should only be given by a trained healthcare professional or a doctor and not self-administered. It is usually administered into the muscle of the upper arm, but in children, it may also be given in the thigh muscle. Follow your doctor's instructions carefully to get the most benefit from the Quadri Meningo Vaccine.
No, the Quadri Meningo Vaccine will not cause meningococcal disease. It works by helping your body produce antibodies against the disease, so that if you are exposed to it in the future, your body can fight the infection.